| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jae Seung Chang, Nam Young Lee, Yong Min Ahn, Yong Sik Ki. The sustained effects of aripiprazole-augmented clozapine treatment on the psychotic symptoms and metabolic profiles of patients with refractory schizophrenia. Journal of clinical psychopharmacology. vol 32. issue 2. 2012-06-18. PMID:22388155. |
the sustained effects of aripiprazole-augmented clozapine treatment on the psychotic symptoms and metabolic profiles of patients with refractory schizophrenia. |
2012-06-18 |
2023-08-12 |
Not clear |
| Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Haruo Kashim. Factors associated with response to clozapine in schizophrenia: a review. Psychopharmacology bulletin. vol 44. issue 1. 2012-06-11. PMID:22506438. |
factors associated with response to clozapine in schizophrenia: a review. |
2012-06-11 |
2023-08-12 |
Not clear |
| Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Haruo Kashim. Factors associated with response to clozapine in schizophrenia: a review. Psychopharmacology bulletin. vol 44. issue 1. 2012-06-11. PMID:22506438. |
clozapine has been serving as the gold standard medication for patients with treatment-resistant schizophrenia who failed to respond to other antipsychotics. |
2012-06-11 |
2023-08-12 |
Not clear |
| Katarzyna Kucharska-Pietura, Ann Mortimer, Aneta Tylec, Andrzej Czernikiewic. Social cognition and visual perception in schizophrenia inpatients treated with first-and second-generation antipsychotic drugs. Clinical schizophrenia & related psychoses. vol 6. issue 1. 2012-06-06. PMID:22453865. |
the aim of our study was to assess social cognition in schizophrenia inpatients being treated with first-generation antipsychotic drugs (fgas), n=28 (perphenazine and haloperidol, fgas) or with second-generation antipsychotic drugs (sgas), n=56 (olanzapine and clozapine, sgas). |
2012-06-06 |
2023-08-12 |
Not clear |
| Marie Humbert-Claude, Elisabeth Davenas, Florence Gbahou, Ludwig Vincent, Jean-Michel Arran. Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo. Psychopharmacology. vol 220. issue 1. 2012-06-04. PMID:21912901. |
brain histamine receptors may play a role in schizophrenia and its treatment, but their involvement in the profile of clozapine remained unknown. |
2012-06-04 |
2023-08-12 |
Not clear |
| S Hossein Fatemi, Timothy D Folsom, Teri J Reutiman, Jessica Novak, Rachelanne H Enge. Comparative gene expression study of the chronic exposure to clozapine and haloperidol in rat frontal cortex. Schizophrenia research. vol 134. issue 2-3. 2012-06-04. PMID:22154595. |
we hypothesized that there would be altered expression of specific genes associated with the etiology or treatment of schizophrenia in frontal cortex of rats that received chronic treatment with a typical apd (haloperidol) vs. an atypical apd (clozapine). |
2012-06-04 |
2023-08-12 |
rat |
| S Hossein Fatemi, Timothy D Folsom, Teri J Reutiman, Jessica Novak, Rachelanne H Enge. Comparative gene expression study of the chronic exposure to clozapine and haloperidol in rat frontal cortex. Schizophrenia research. vol 134. issue 2-3. 2012-06-04. PMID:22154595. |
our results show that clozapine and haloperidol cause changes in levels of many important genes that may be involved in etiology and treatment of schizophrenia. |
2012-06-04 |
2023-08-12 |
rat |
| Oguz Mutlu, Güner Ulak, Ipek Komsuoglu Celikyurt, Pelin Tanyeri, Furuzan Yıldız Akar, Faruk Erde. Effects of olanzapine and clozapine on memory acquisition, consolidation and retrieval in mice using the elevated plus maze test. Neuroscience letters. vol 501. issue 3. 2012-05-31. PMID:21782893. |
clozapine and olanzapine are antipsychotic drugs commonly used to treat schizophrenia and psychosis; however, few studies have investigated their effects on cognitive function using animal models. |
2012-05-31 |
2023-08-12 |
mouse |
| Oguz Mutlu, Güner Ulak, Ipek Komsuoglu Celikyurt, Pelin Tanyeri, Furuzan Yıldız Akar, Faruk Erde. Effects of olanzapine and clozapine on memory acquisition, consolidation and retrieval in mice using the elevated plus maze test. Neuroscience letters. vol 501. issue 3. 2012-05-31. PMID:21782893. |
thus, these results at least suggest that olanzapine can be a superior treatment for schizophrenia compared to clozapine. |
2012-05-31 |
2023-08-12 |
mouse |
| David T Chau, Jayme Ahmed, Thomas T Wang, Haiyi Xie, Ree Dawson, Alan I Gree. Raclopride lessens the ability of clozapine to suppress alcohol drinking in Syrian golden hamsters. Neuropharmacology. vol 61. issue 4. 2012-05-25. PMID:21619888. |
we have proposed that clozapine, through its weak da d2 receptor blocking action, coupled with its ability to potentiate noradrenergic and serotonergic activity, may ameliorate a dysfunction in the mesocorticolimbic da reward circuitry that underlies alcohol use disorder in patients with schizophrenia. |
2012-05-25 |
2023-08-12 |
Not clear |
| David T Chau, Jayme Ahmed, Thomas T Wang, Haiyi Xie, Ree Dawson, Alan I Gree. Raclopride lessens the ability of clozapine to suppress alcohol drinking in Syrian golden hamsters. Neuropharmacology. vol 61. issue 4. 2012-05-25. PMID:21619888. |
these data suggest that clozapine may limit alcohol drinking in the golden hamster (and possibly in patients with schizophrenia) in part because of its weak blockade of the da d2 receptor. |
2012-05-25 |
2023-08-12 |
Not clear |
| Susan Brosnan, Elizabeth Barron, L J Sah. Health literacy and the clozapine patient. Perspectives in public health. vol 132. issue 1. 2012-05-10. PMID:22458151. |
to estimate the prevalence of limited health literacy in patients receiving clozapine for schizophrenia. |
2012-05-10 |
2023-08-12 |
Not clear |
| Falko Biedermann, Nicole Pfaffenberger, Susanne Baumgartner, Georg Kemmler, W Wolfgang Fleischhacker, Alex Hofe. Combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes. The journal of ECT. vol 27. issue 4. 2012-05-08. PMID:22124226. |
combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes. |
2012-05-08 |
2023-08-12 |
Not clear |
| Falko Biedermann, Nicole Pfaffenberger, Susanne Baumgartner, Georg Kemmler, W Wolfgang Fleischhacker, Alex Hofe. Combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes. The journal of ECT. vol 27. issue 4. 2012-05-08. PMID:22124226. |
we report here on clinical and cognitive outcomes of a treatment-resistant schizophrenia patient treated with clozapine and right unilateral ect.the patient was administered 300 mg of clozapine and 12 right unilateral ect sessions. |
2012-05-08 |
2023-08-12 |
Not clear |
| Eunice Y Yuen, Xiangning Li, Jing Wei, Masakuni Horiguchi, Herbert Y Meltzer, Zhen Ya. The novel antipsychotic drug lurasidone enhances N-methyl-D-aspartate receptor-mediated synaptic responses. Molecular pharmacology. vol 81. issue 2. 2012-05-04. PMID:22072817. |
in this study, we found that lurasidone, as well as the prototypical atypical apd clozapine, restored nmdar-mediated synaptic responses to normal levels in the pcp model of schizophrenia. |
2012-05-04 |
2023-08-12 |
rat |
| D van Dam, T M Bosch, E J Mookhoek, J E Hoven. [Treatment of clozapine-induced tachycardia with propranolol complicated by psoriasis]. Tijdschrift voor psychiatrie. vol 54. issue 3. 2012-05-03. PMID:22422422. |
a 25-year-old male developed sinus tachycardia after given clozapine for treatment-resistant psychosis in schizophrenia. |
2012-05-03 |
2023-08-12 |
Not clear |
| Naresh Nebhinani, Sandeep Grove. Clozapine v. chlorpromazine in treatment-naive first-episode schizophrenia. The British journal of psychiatry : the journal of mental science. vol 200. issue 2. 2012-05-02. PMID:22297596. |
clozapine v. chlorpromazine in treatment-naive first-episode schizophrenia. |
2012-05-02 |
2023-08-12 |
Not clear |
| Stephen Perks, Sherryl Robertson, Alison Haywood, Beverley Glas. Clozapine repackaged into dose administration aids: a common practice in Australian hospitals. The International journal of pharmacy practice. vol 20. issue 1. 2012-05-01. PMID:22236174. |
clozapine is an atypical antipsychotic used in the treatment of schizophrenia. |
2012-05-01 |
2023-08-12 |
Not clear |
| John M Kan. Addressing nonresponse in schizophrenia. The Journal of clinical psychiatry. vol 73. issue 2. 2012-05-01. PMID:22401484. |
clozapine is recommended for patients with schizophrenia who have not responded to 2 other antipsychotic trials of adequate duration, but many physicians are hesitant to prescribe clozapine due to the complexity of the treatment regimen and the possibility of severe adverse effects. |
2012-05-01 |
2023-08-12 |
Not clear |
| Zahinoor Ismail, Alette M Wessels, Hiroyuki Uchida, Wenzie Ng, David C Mamo, Tarek K Rajji, Bruce G Pollock, Benoit H Mulsant, Robert R Bie. Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 20. issue 1. 2012-04-24. PMID:21422906. |
age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia. |
2012-04-24 |
2023-08-12 |
Not clear |